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ABSTRACT Insights into disease susceptibility as well as the efﬁcacy of vaccines
against typhoid and other enteric pathogens may be informed by better under-
standing the relationship between the effector immune response and the gut micro-
biota. In the present study, we characterized the composition (16S rRNA gene proﬁl-
ing) and function (RNA sequencing [RNA-seq]) of the gut microbiota following
immunization and subsequent exposure to wild-type Salmonella enterica serovar Ty-
phi in a human challenge model to further investigate the central hypothesis that
clinical outcomes may be linked to the gut microbiota. Metatranscriptome analysis
of longitudinal stool samples collected from study subjects revealed two stable pat-
terns of gene expression for the human gut microbiota, dominated by transcripts
from either Methanobrevibacter or a diverse representation of genera in the Firmic-
utes phylum. Immunization with one of two live oral attenuated vaccines against
S. Typhi had minimal effects on the composition or function of the gut microbiota. It
was observed that subjects harboring the methanogen-dominated transcriptome
community at baseline displayed a lower risk of developing symptoms of typhoid
following challenge with wild-type S. Typhi. Furthermore, genes encoding antioxi-
dant proteins, metal homeostasis and transport proteins, and heat shock proteins
were expressed at a higher level at baseline or after challenge with S. Typhi in sub-
jects who did not develop symptoms of typhoid. These data suggest that functional
differences relating to redox potential and ion homeostasis in the gut microbiota
may impact clinical outcomes following exposure to wild-type S. Typhi.
IMPORTANCE S. Typhi is a signiﬁcant cause of systemic febrile morbidity in settings
with poor sanitation and limited access to clean water. It has been demonstrated
that the human gut microbiota can inﬂuence mucosal immune responses, but there
is little information available on the impact of the human gut microbiota on clinical
outcomes following exposure to enteric pathogens. Here, we describe differences in
the composition and function of the gut microbiota in healthy adult volunteers en-
rolled in a typhoid vaccine trial and report that these differences are associated with
host susceptibility to or protection from typhoid after challenge with wild-type S.
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Typhi. Our observations have important implications in interpreting the efﬁcacy of
oral attenuated vaccines against enteric pathogens in diverse populations.
KEYWORDS 16S rRNA gene proﬁling, Salmonella, immunization,
metatranscriptomics, methanogens, microbiome, typhoid disease
Salmonella enterica serovar Typhi (S. Typhi) is a human-restricted enteric pathogenthat causes typhoid fever affecting an estimated 11.9 to 26.9 million people
annually (1), principally those living in low-resource or conﬂict settings and travelers to
regions of endemicity. Ty21a, a live attenuated oral vaccine, is one of two widely
available vaccines for preventing typhoid (2). Immunization with Ty21a induces both
humoral immunity (mucosal and serum antibodies and B memory cells) and cell-
mediated immune (CMI) responses (3). Local and systemic antibodies to S. Typhi
antigens are thought to be active against typhoid bacilli when they are extracellular,
whereas the CMI response plays an important role in eliminating intracellular S. Typhi
(4). In a prior study, we investigated the relationship between the gut microbiota and
deﬁned S. Typhi-speciﬁc immunological responses in volunteers receiving the Ty21a
vaccine. We observed a signiﬁcant association between a multiphasic CMI response and
a more diverse gut microbiota—with more than 200 operational taxonomic units
(OTUs) differentiating multiphasic from late responders (5).
The development of a human challenge model provided us with a unique oppor-
tunity to characterize the composition and function of the gut microbiota following
immunization and subsequent exposure to S. Typhi and to further investigate the
central hypothesis that mucosal immune responses are linked to the gut microbiota.
Mounting evidence suggests that microbiota composition may be linked to immuno-
genicity and oral vaccine efﬁcacy (6–9). For example, excessive bacterial growth in the
small intestine of children living in resource-limited settings might contribute to the
low antibody titers seen in response to an oral live attenuated Vibrio cholerae vaccine,
CVD 103-HgR (10). Moreover, reduced vaccine efﬁcacy and immunogenicity in
resource-limited regions have also been reported with other vaccines, including rota-
virus and oral polio vaccines (8, 11, 12). Despite these limitations, live attenuated oral
vaccines continue to have great potential to reduce disease transmission and prevent
clinical infection around the world. Through studies such as those presented here, there
is the potential for new insights that may ultimately be leveraged to improve protective
efﬁcacy of oral vaccines against typhoid and other enteric infections.
RESULTS
To investigate the efﬁcacy of immunization with two live oral attenuated vaccines
against S. Typhi (3 doses of Ty21a vaccine or one dose of the candidate vaccine,
M01ZH09) and subsequent challenge with wild-type (wt) S. Typhi Quailes strain and the
effects on the composition and function of the gut microbiota, we carried out longi-
tudinal 16S rRNA gene and metatranscriptomic analyses of stool samples obtained
from 30 healthy adult trial subjects who were randomly assigned to one of the three
vaccine groups in a study performed in Oxford, United Kingdom (13). These volunteers
were healthy males or nonpregnant females, between 18 and 60 years of age and with
no history of typhoid vaccination or S. Typhi infection.
Compositional profiling of microbial communities using 16S rRNA gene se-
quencing. We generated 89 million high-quality sequence reads from bacterial 16S
rRNA gene V3-V4 amplicons, with a mean (standard deviation [SD]) of 157,048
(160,204) reads per stool sample. A k-means clustering pipeline grouped the 16S
rRNA gene data from all samples into three clusters characterized by (i) high relative
abundance of Faecalibacterium (Fig. 1A, green vertical bar), (ii) high relative abundance
of Faecalibacterium and Bacteroides (Fig. 1A, red vertical bar), or (iii) a high relative
abundance of reads from diverse Firmicutes (Fig. 1A, blue vertical bar). The community
that was dominated by reads from Faecalibacterium (green) displayed a signiﬁcantly
lower taxonomic diversity than the other two communities (linear mixed-effects model,
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P value  0.01) (Fig. 1B). No signiﬁcant difference in taxonomic diversity as calculated
with the Shannon diversity index was observed between subjects who did (typhoid
diagnosis [TD]) or did not (no TD) develop typhoid (Fig. 1C). It was noted that the
distribution of samples within the 16S rRNA gene clusters was skewed with regard to
vaccine group, with the placebo recipients represented in the Faecalibacterium-
dominated or diverse Firmicutes community, the majority of Ty21a recipients repre-
sented in the Faecalibacterium and Bacteroides-dominated community, and the major-
ity of M01ZH09 recipients represented in the diverse Firmicutes community. These
differences, reﬂecting the random assignment of subjects to speciﬁc vaccine groups at
the time of recruitment, potentially make comparison of outcomes based on immuni-
zation challenging.
Spearman’s rank correlation was applied, using averaged genus abundances from
two baseline samples, to identify relationships between taxa (Fig. 1D). Within the
Bacteroidetes phylum, an inverse correlation between Bacteroides and Prevotella was
FIG 1 16S rRNA proﬁling of longitudinal samples. (A) Longitudinal 16S rRNA data were used as input for an in-house k-means clustering pipeline. Vertical side
bars (green, red, and blue) represent three clusters that were identiﬁed. These clusters are dominated by (i) Faecalibacterium, (ii) Faecalibacterium and
Bacteroides, and (iii) Firmicutes, respectively. Horizontal side bars are color coded as follows: blue, Firmicutes; red, Bacteroidetes; green, Actinobacteria; purple,
Proteobacteria; gray, Verrucomicrobia; brown, Euryarchaeota; orange, other. (B and C) Shannon diversity was calculated for each community (B) and clinical
outcome (no TD [NTD] or TD) (C). (D) Relationship between genera was assessed by Spearman’s rank correlation coefﬁcient using average genus abundances
at baselines. The size and color of circles represent the correlation shown in the color bar. (E) Bray-Curtis dissimilarity values were calculated and compared
between different subjects at the same time point (i.e., interindividual) as well as within each individual among different time points (i.e., intraindividual).
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observed as previously reported (14).Methanobrevibacter was positively correlated with
Akkermansia, Parabacteroides, Ruminococcus, Coprococcus, and Oscillospira and in-
versely correlated with Faecalibacterium and Roseburia. Consistent with previous results
from our laboratory and others, we observed marked interindividual variability in the
composition of the microbiota, although longitudinal samples collected from the same
individual displayed higher similarity to each other than to those collected from
unrelated individuals (Fig. 1E).
Taxonomic profiling of microbial communities using metatranscriptomic anal-
ysis.mRNA was extracted from a subset of the same stool samples that were processed
for 16S rRNA gene proﬁling, including samples collected at two baselines, two vacci-
nation time points, prechallenge, and two postchallenge time points (day 1 and day 7
after challenge). Whole-community RNA sequencing (RNA-seq) was performed on the
Illumina HiSeq 2000 platform, generating an average of 71.6  26.2 million paired-end
reads per sample. After quality control (QC) and ﬁltration of rRNA and human RNA
reads, 50.4  26.0 million reads per sample were used as input for transcriptomic
community proﬁling using unique clade-speciﬁc marker genes by MetaPhlAn v2.0 (15).
The k-means clustering pipeline was used to analyze the taxonomic composition of
the entire metatranscriptomic data set, and this analysis identiﬁed two clusters. These
were (i) a set of samples in which Methanobrevibacter transcripts were highly abundant
(59.0%  23.4%) and (ii) another set of samples characterized by transcript abundance
from a large number of genera across multiple phyla (Fig. 2A), a ﬁnding similar to that
previously described by our laboratory (16). These ﬁndings were supported by
principal-component analysis (PCA), which conﬁrmed two main clusters distinguished
by the abundance of Methanobrevibacter transcripts (Fig. 2E). Using a linear mixed-
effects model, the Shannon diversity of the methanogen dominated (1.45  0.60) and
the diverse Firmicutes (2.25  0.42) cluster was found to be signiﬁcantly different
(P values  0.01) (Fig. 2B). In contrast, the Shannon diversity values of the subjects who
did or did not develop typhoid were not signiﬁcantly different (P value  0.15) (Fig. 2C).
Spearman’s rank correlation coefﬁcient was applied to assess the pairwise relation-
ship between genera in the metatranscriptomic data set using averaged genus abun-
dances from two baseline samples (Fig. 2D). Methanobrevibacter showed a strong
negative correlation with several Firmicutes genera, including Eubacterium (  0.64,
P value  0.01), Faecalibacterium (  0.54, P value  0.01), Ruminococcus (  0.51,
P value  0.01), Blautia (  0.55, P value  0.01), and Roseburia (  0.49, P
value  0.01), as well as Bacteroides (  0.61, P value  0.01), whereas these genera
were positively correlated with each other. Bacteroides and Prevotella also displayed an
inverse correlation (  0.45, P value  0.02), similar to what was observed in the 16S
rRNA gene data set. We assessed overall correlation between the 16S rRNA gene data
and the metatranscriptome data (see Fig. S1 in the supplemental material); however, no
signiﬁcant relationship was observed, as previously described (16).
Pairwise comparison of samples within individuals using the Bray-Curtis (B-C) dis-
similarity index allowed for quantiﬁcation of taxonomic changes in the metatranscrip-
tomic data set over time (17). Longitudinal analysis of the metatranscriptomic data
revealed that the taxonomic proﬁles were relatively stable within an individual, regard-
less of vaccine received or the outcome after challenge (Fig. 3A and B; Table S1). The
methanogen-dominated community (B-C dissimilarity  0.30  0.20) appeared to be
more stable over time than the diverse Firmicutes community, although this was not
statistically signiﬁcant (B-C dissimilarity  0.38  0.15; P value  0.096 using linear
mixed-effects model) (Fig. 3C).
Functional differences between transcriptome community types. Comparison of
the functional properties of the transcriptome communities as represented by Gene
Ontology (GO) terms revealed signiﬁcant and consistent differences over time (Fig. 4).
A total of 2,877 KEGG orthologs (KOs) were identiﬁed in the metatranscriptomic data
set with 75.5% of these shared between the methanogen-dominated and diverse
communities. Each community type also contained a subset of unique KOs represent-
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ing 18.2% of the total in the methanogen-dominated community versus 6.3% in the
diverse Firmicutes community. As represented by GO terms, genes present only in the
methanogen-dominated community were involved in methanogenesis (GO:0015948),
cellular response to radiation (GO:0071478), divalent inorganic cation homeostasis
(GO:0072507), protoporphyrinogen IX biosynthesis (GO:0006782), one-carbon meta-
bolism (GO:0006730), and posttranslational protein modiﬁcation (GO:0043687). In con-
trast, the diverse Firmicutes community was characterized by a signiﬁcantly greater
abundance of genes involved in ﬂagellum assembly (GO:0044780), ﬂagellum-
dependent cell motility (GO:0071973), sporulation resulting in formation of a cellular
spore (GO:0030435), monosaccharide transport (GO:0015749), mannose metabolism
(GO:0006013), and cellulose catabolism (GO:0030245). We evaluated the quality of the
RNA-seq results by quantitative reverse transcriptase PCR (qRT-PCR), using a subset of
genes that were differentially expressed between the two transcriptome communities
(ﬂagellar hook protein FlgE [KO02390], ﬂagellin [KO02406], an uncharacterized protein
from Methanobrevibacter [KO06933], and methanol corrinoid protein [KO14081]) (Ta-
FIG 2 Metatranscriptome proﬁling of longitudinal samples. (A) Longitudinal metatranscriptome data were used as input for an in-house k-means clustering
pipeline. Vertical side bars (red and blue) represent two community types that were identiﬁed: methanogen-dominated and diverse Firmicutes, respectively.
Horizontal side bars are color coded as follows: blue, Firmicutes; red, Euryarchaeota; green, Bacteroidetes; purple, Actinobacteria; gray, Proteobacteria; brown,
Verrucomicrobia. (B) Shannon diversity values were calculated for the two communities and were signiﬁcantly different (P values  0.01). (C) Shannon diversity
values calculated between the two clinical outcomes (no TD [NTD] or TD) were not signiﬁcantly different (P values  0.15). (D) Relationship between genera
was assessed by Spearman’s rank correlation coefﬁcient using average genus abundances at baselines. Size and color of circles represent the correlation shown
in the color bar. (E) Principal-component analysis was applied to visualize dissimilarities among samples.
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ble S2). We observed a high correlation of fold changes in these genes as measured by
both techniques (Fig. S1), lending additional support to the notion that these tran-
scriptome communities differ with regard to function.
Global differential gene expression associated with vaccination. There was no
change in the global gene expression proﬁle of the gut microbiome (i.e., the sum of the
gene expression proﬁle from all taxa), before and after placebo treatment, as expected.
Similarly, relatively few genes were differentially expressed before and after immuni-
zation in volunteers who received Ty21a (4 genes downregulated and 4 genes upregu-
lated following immunization). These ﬁndings are consistent with a previous report that
immunization with Ty21a has minimal effects on the gut microbiota (16). In contrast, 72
genes were differentially expressed globally in volunteers receiving the M01ZH09
vaccine. Twenty-nine methanogenesis-associated genes were upregulated in this treat-
ment group. While it is possible that this difference may be related to vaccination, it is
perhaps more likely that the differentially expressed (DE) genes reﬂect ﬂuctuation in the
taxonomic composition in these samples over time.
Association between community type and clinical outcome. Of the 30 study
subjects included in this study, 13 individuals (43%) did not fulﬁll the deﬁnition for
typhoid diagnosis (TD) after challenge with wild-type S. Typhi, including 50% of the
placebo control group (13). The availability of longitudinal 16S rRNA gene and meta-
transcriptome data from study participants provided the opportunity to identify po-
tential differences in the composition and/or function of the gut microbiota that was
associated with clinical outcome.
FIG 3 RNA-seq transcript dynamics and dissimilarity across subjects. (A) Relative genus abundance for each subject over time. D and M stand for diverse and
Methanobrevibacter-dominated community, respectively. (B) Bray-Curtis dissimilarity for each of the subjects in this study. Each box plot represents the
dissimilarity in the composition of the microbiota between all longitudinal samples collected from the same subject. Five statistical values are indicated on each
box plot, including minimum, ﬁrst quartile, median, third quartile, and maximum. (C) Bray-Curtis dissimilarity values were calculated and compared among
different subjects at the same time point (i.e., interindividual) as well as within each individual among different time points (i.e., intraindividual).
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We observed a difference in clinical outcome (TD versus no TD) following challenge
with wild-type S. Typhi that was associated with transcriptome communities. Sixty
percent of the volunteers whose microbiome contained a high relative abundance of
Methanobrevibacter transcripts did not develop TD symptoms following challenge. In
contrast, 65% of the volunteers whose microbiome contained few, if any, Methanobre-
vibacter transcripts did exhibit clinical symptoms consistent with TD. To assess whether
clinical outcome was distributed uniformly across each gut transcriptome community
(methanogen-dominated or diverse Firmicutes), the chi-square test was applied (P value
of 0.096), and the results, albeit not statistically signiﬁcant, suggested that a difference
between the gut communities was associated with a risk of TD.
A mixed-effects regression model was applied to the longitudinal data to estimate
the mean relative abundance of each taxon at different time points (baseline, postvac-
cine, and postchallenge) among those subjects who did or did not develop TD, and
P values were computed to compare the two groups at each time point (Table 1). This
analysis revealed a signiﬁcant association between the high abundance of Methano-
brevibacter transcripts and lack of typhoid disease following challenge. In contrast,
Eubacterium transcripts were found at a signiﬁcantly higher relative abundance in
subjects who developed TD at baseline, postvaccine, and postchallenge, suggesting a
relationship between Eubacterium and TD; Faecalibacterium, Bacteroides, Alistipes, and
Prevotella also showed signiﬁcantly higher relative abundances in TD subjects during
one or two of these time periods.
Taxon-specific differential gene expression associated with clinical outcome.
Using KEGG orthologs (KOs), we evaluated differential expression between TD and
no-TD subjects in the two baseline samples and in samples collected 1 day (D1) or
FIG 4 Comparative analysis of RNA-seq data at baseline. (A) Shannon diversities of the two transcriptome communities were signiﬁcantly different (P  0.001).
(B) Relative abundances of genera in each transcriptome community. Genera with signiﬁcantly different abundances between the two communities are denoted
with asterisks. (C) Number of unique and common KEGG orthologues detected in each transcriptome community. (D) Gene ontology groups that were
signiﬁcantly different between the two transcriptome communities are shown (false discovery rate, 0.05).
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1 week (D7) after challenge with wild-type S. Typhi (Fig. 5). We observed that several
enzymes and proteins associated with oxidative stress were expressed at higher levels
in no-TD volunteers across all time points in this study. Genes encoding superoxide
dismutase (K04564) in Barnesiella and catalase (K03781) and Mn-containing catalase
(K07217) in Bacteroides were expressed at higher levels in no-TD volunteers at baseline.
The latter enzyme, together with glutathione peroxidase (K00432) of Bacteroides, was
also expressed at higher levels in no-TD volunteers 24 h postchallenge. Similarly,
Bifidobacterium peroxiredoxin Q/BCP (K03564) was more abundant in samples from
no-TD volunteers at baseline and 7 days postchallenge.
We also observed that genes encoding iron-sulfur binding enzymes (K00196 and
K14127) were globally expressed at higher levels in no-TD volunteers at 24 h postchal-
TABLE 1 Mean relative abundance of genera at different time pointsa
Genus
Baseline Postvaccine Postchallenge
No TD TD No TD TD No TD TD
Blautia 0.069 0.071 0.084 0.127 0.066 0.079
Ruminococcus 0.090 0.081 0.088 0.074 0.094 0.100
Faecalibacterium 0.048 0.082 0.048 0.077 0.0451 0.0871
Subdoligranulum 0.075 0.052 0.055 0.051 0.048 0.055
Eubacterium 0.0282 0.0692 0.0303 0.0613 0.0354 0.0734
Roseburia 0.014 0.015 0.040 0.018 0.015 0.026
Coprococcus 0.021 0.016 0.019 0.015 0.018 0.021
Dorea 0.009 0.011 0.007 0.012 0.010 0.015
Methanobrevibacter 0.315 0.180 0.346 0.170 0.3675 0.1425
Parabacteroides 0.071 0.114 0.065 0.075 0.050 0.080
Bacteroides 0.052 0056 0.0286 0.0636 0.034 0.059
Alistipes 0.025 0.029 0.018 0.025 0.0217 0.0387
Prevotella 0.010 0.037 0.0068 0.0408 0.019 0.030
Sutterellaceae, unknown genus 0.0209 0.0489 0.025 0.050 0.01610 0.03510
Bifidobacterium 0.017 0.029 0.012 0.028 0.043 0.050
Collinsella 0.011 0.017 0.013 0.016 0.020 0.018
Sutterella 0.006 0.011 0.007 0.013 0.006 0.014
Akkermansia 0.008 0.017 0.010 0.009 0.008 0.010
aPairs with a P value of 0.1 are denoted by superscript numbers, and the corresponding genera are
marked in bold. Superscript numbers correspond to P values as follows: 1, P  0.075; 2, P  0.033; 3, P 
0.097; 4, P  0.057; 5, P  0.058; 6, P  0.061; 7, P  0.021; 8, P  0.078; 9, P  0.071; 10, P  0.091.
FIG 5 Signiﬁcant differences in the gene expression proﬁles between no-TD and TD subjects at baseline (BL), 1 day postchallenge (Post-chall 1D), or 7 days
postchallenge (Post-chall 7D).
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lenge (Fig. 5). NADH dehydrogenase, which carries crucial iron-sulfur center subunits for
electron transfer, was overexpressed in no-TD volunteers at baseline in the genera
Akkermansia (K00331), Blautia (K00335), and Bacteroides (K03885), as well as 24 h
postchallenge globally (K00332 and K03942). Other genes encoding iron-sulfur-
containing enzymes, including ferredoxin oxidoreductase using pyruvate (K00169 to
K00172) and 2-oxoglutarate (K00187 and K00189) as the substrate, were globally
overexpressed in no-TD volunteers at 24 h postchallenge.
Copper is another redox-active metal (18), and genes encoding copper homeostasis
proteins displayed a higher level of expression in no-TD volunteers at baseline in
Bacteroides (K06079) and Blautia (K06201), the iron/zinc/copper transport system ATD-
binding protein (K11706) of Streptococcus was expressed at higher levels in no-TD
volunteers at baseline, and the copper chaperone (K07213) was overexpressed globally
in no-TD volunteers 24 h postchallenge. The Gene Ontology term copper ion binding
(GO:0005507) also showed higher expression in no-TD volunteers at 24 h postchal-
lenge, consistent with the KEGG analysis results.
In addition to redox-active metals, we found that genes encoding nickel-related
proteins displayed a higher level of expression in no-TD volunteers at baseline and 24 h
postchallenge. These include cobalt/nickel transport system permease protein (K02007,
global), hydrogenase nickel incorporation protein (K04651, global), and CopG family
transcriptional regulator, nickel-responsive regulator (K07722, global and in Parabac-
teroides), which were expressed at higher levels in no-TD volunteers 24 h postchallenge,
as well as peptide/nickel transport system ATD-binding protein (K02031 in Eubacterium
and K02032 in Dorea), which was more abundant in no-TD volunteers at baseline. In
agreement with the above results, the GO terms nickel cation binding (GO:0016151)
and divalent inorganic cation homeostasis (GO:0072507) were observed to be overrep-
resented in no-TD volunteers at 24 h postchallenge.
A gene encoding the heat shock protein HspR, which belongs to MerR transcrip-
tional regulator (K13640), was expressed at higher levels in no-TD subjects at 24 h
postchallenge. MerR family proteins have been known to activate the expression of
genes required for metal efﬂux or detoxiﬁcation, defense against oxidative stress, and
drug resistance (18).
Comparison of the metatranscriptomic data sets from no-TD versus TD volunteers
24 h postchallenge revealed a higher level of expression of several stress response
genes in no-TD volunteers, including the chaperonins GroEL (K04077) and GroES
(K04078) from multiple genera, including Blautia, Coprococcus, Bifidobacterium, Strep-
tococcus, Sutterella, Barnesiella, Bacteroides, and Alistipes. In addition, genes encoding
the multiple stress resistance protein BhsA (K12151) and heat shock proteins (K03283
and 13640) were expressed at a higher level in no-TD volunteers at 24 h postchallenge.
The GO terms chaperone binding (GO:0051087), unfolded protein binding (GO:
0051082), and heat shock protein binding (GO:0031072) exhibited similar expression
patterns as the KEGG proﬁles.
Flagellum-associated proteins from Eubacterium and Roseburia were overexpressed
in TD volunteers at multiple times before challenge with S. Typhi. GO terms bacterial-
type ﬂagellum assembly (GO:0044780) and bacterial-type ﬂagellum-dependent cell
motility (GO:0071973) also displayed higher levels of expression in TD volunteers at
baseline.
DISCUSSION
One of the most important roles of the gut microbiota in health is to inhibit
colonization and overgrowth of pathogenic species—a process called “colonization
resistance.” This process involves a complex set of interactions among the constituents
of the microbiota and between the microbiota and host (19, 20). Metatranscriptome
analysis revealed two patterns of gene expression in the gut microbiota of our vaccine
study participants that persisted from baseline through vaccination and challenge—the
ﬁrst was characterized by a high relative abundance of transcripts from the methano-
gen Methanobrevibacter, and the second was characterized by a diverse set of tran-
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scripts from representatives of the Firmicutes phylum. These two transcriptome com-
munity types were associated with different clinical outcomes following challenge with
wild-type S. Typhi, i.e., the presence of Methanobrevibacter was associated with no TD,
whereas the Firmicutes were associated with TD. One question raised by these results
is whether, and how, the functional differences between the two transcriptome com-
munities contributed to the different clinical outcomes that were observed.
Macrophages and lymphocytes are prominent in gut inﬁltrates following exposure
to S. Typhi (21, 22), and macrophages are avid producers of reactive oxygen species
(ROS) that exert bactericidal effects (23). The Methanobrevibacter-dominated commu-
nity was associated with a lower risk of developing TD following challenge with
wild-type S. Typhi. It is known that H2-utilizing methanogenic archaea in the human gut
microbiota are extremely sensitive to free radicals, requiring a strongly reduced gut
environment (redox potential  200 mV) to survive (24, 25). It is possible that the
highly reduced environment required for the survival of gut methanogens mitigates
the effect of ROS produced following Salmonella infection, thereby altering the envi-
ronmental signals that trigger a cascade of virulence factors necessary for host invasion
(26). This notion was also supported by the observation that genes encoding multiple
enzymatic antioxidants in several genera in the Methanobrevibacter-dominated com-
munity were highly expressed both at baseline and following challenge with wild-type
S. Typhi in no-TD subjects. Our data suggest that multiple mechanisms may be
employed to control the oxygen concentration in the Methanobrevibacter community
and are consistent with recent reports that methanogenic archaea can be grown in the
presence of oxygen when the culture medium is supplemented with the antioxidants
ascorbic acid, uric acid, and glutathione (27, 28).
Oxidative stress can also disturb the homeostasis of redox-active metals, including
iron, copper, cobalt, and nickel (18), which in turn can act as catalysts to further drive
the production of ROS and reactive nitrogen species (RNS) (29). To maintain an optimal
bioavailable concentration of a metal ion, cellular metabolism must be altered to
balance metal uptake and efﬂux/storage processes. Several other observations from
analysis of the metatranscriptome data suggest potential differences between the
transcriptome community responses to oxidative stress. Subjects who did not develop
typhoid also had a higher level of expression of genes encoding proteins containing
iron-sulfur binding subunits as well as GO terms associated with divalent inorganic
cation homeostasis and nickel/copper/molybdenum binding at baselines or postchal-
lenge. The high expression of genes involved in metal homeostasis might reﬂect a
response to the presumed oxidative stress induced by S. Typhi infection.
In order to invade, enteric pathogens must traverse both the inner and outer mucus
layer that separates the gut lumen from the underlying epithelium. The relative
abundance of Akkermansia spp., a clade of mucin-degrading bacteria, has been re-
ported to correlate with the thickness of the mucus layer (30). It was therefore of
interest to observe a positive correlation between Methanobrevibacter and Akkermansia
in both the 16S rRNA gene and metatranscriptomic data sets, suggesting that potential
differences in the mucus layer among subjects may also contribute to different clinical
outcomes following challenge with wild-type S. Typhi.
Finally, gut methanogens have been reported to play a role in activation of the
adaptive immune response by upregulating cell surface receptors CD86 and CD197 on
monocyte-derived dendritic cells (moDCs) and expression of human -defensin in
moDCs exposed to Methanobrevibacter smithii in vitro (31). These ﬁndings suggest that
methanogenic archaea may possess important immunomodulatory functions that
could potentially impact outcomes following infection with enteric pathogens.
Analysis of the metatranscriptome data revealed that a suite of genes encoding
proteins involved in ﬂagellar biosynthesis and chemotaxis in the motile bacteria
Eubacterium and Roseburia were consistently present at higher abundance in subjects
who developed clinical symptoms following challenge with S. Typhi. It is possible that
this observation reﬂects the fact that the diverse Firmicutes transcriptome community
type is correlated with TD. On the other hand, bacterial ﬂagellins, the major structural
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protein of ﬂagella, and another ﬂagellar hook protein, FlgE, have been reported to play
an important role in mucosal immune activation of the Toll-like receptor 5 (TLR5)
pathway (32–34). Our data are of interest in light of the ﬁndings of Cullender et al., who
reported that antiﬂagellum antibodies immobilize commensal motile bacteria in vitro
and also function to induce downregulation of ﬂagellin gene expression by an un-
known mechanism (35). The signiﬁcantly greater abundance of ﬂagellin genes in TD
subjects is consistent with the possibility of an overall lower level of antiﬂagellin
antibodies in the gut, suggesting possible differences in the innate immune response
among the subjects in this study. While it is not possible to further speculate on the
impact of differences in the overall level of commensal ﬂagellin gene expression on
host immune status and clinical outcome following exposure to wild-type S. Typhi, this
relationship should be further examined in future studies.
To the best of our knowledge, this is the ﬁrst demonstration that differences in the
composition and function of the human gut microbiome correlate with the develop-
ment of typhoid symptoms following exposure to wild-type S. Typhi. These observa-
tions have important implications in interpreting the efﬁcacy of oral attenuated vac-
cines against enteric pathogens in diverse populations. The association between
Methanobrevibacter and lack of disease symptoms is of interest, especially given that
methanogens appear to represent a relatively minor fraction of the gut microbiota (36).
Few studies have examined the contribution of methanogens to gut microbiota
function. A previous study from our laboratory (16) examining the impact of a Lacto-
bacillus probiotic on the function of the gut microbiota also described a transcriptome
community dominated by Methanobrevibacter transcripts. Taken together, the data
from these two studies are consistent with the notion that methanogens may be
critically important to the overall function of the gut microbiota in a subset of
individuals.
There is one important caveat to our study. The small intestine is the site of invasion
for S. Typhi, from which it can disseminate to other tissues, including the liver, spleen,
and gallbladder (37). Fecal samples are most representative of the ecosystem present
in the colon; however, it is not practical to sample the microbiome of the small intestine
in longitudinal human studies. Our data indicate that further exploration of the
mechanisms by which differences in the gut microbiome can impact susceptibility to
enteric pathogens in both humans and animal models may provide important new
insights into the interplay between host, pathogen, and the microbiome.
MATERIALS AND METHODS
Subject recruitment and sample collection. Longitudinal fecal samples were collected from
healthy adults recruited in Oxford, United Kingdom (13). Volunteers received 3 doses of oral Ty21a (a
licensed live attenuated typhoid vaccine, strain Ty21a), a single dose of M01ZH09 (an attenuated live
typhoid vaccine candidate strain), or placebo, followed 28 days later by challenge with 104 CFU of
wild-type (wt) S. Typhi (Quailes strain), monitoring of clinical symptoms and hematological and bio-
chemical responses, and daily microbiological sampling. Stool samples were collected at the screening
interview (baseline 1), prior to the ﬁrst vaccination visit (baseline 2), two time points during vaccination
(days 28 and 26) for placebo and M01ZH09 groups but four time points during vaccination (days
32, 30, 28, and 26) for the Ty21a group, prior to challenge with S. Typhi (day 0), and ﬁve time
points after challenge at day 0: 12 h, day 1, day 3, day 7, and day 10. Written informed consent was
obtained, and all procedures were approved by National Research Ethics Service South Central—Oxford
A (11/SC/0302). The clinical trial was sponsored and monitored by the Oxford University Clinical Trials
and Research Governance Department. After collection, stool was mixed with RNAlater, homogenized,
aliquoted into cryovials, and stored at 80°C until further processing.
DNA extraction and 16S rRNA gene sequencing. DNA was extracted from each of 283 stool
specimens. For processing, samples were thawed at 4°C and, in aliquots of 0.15 g per tube, resuspended
in 1 ml of 1 phosphate-buffered saline. Cell lysis was initiated with two enzymatic incubations, ﬁrst,
using 5 l of lysozyme (10 mg ml1; Amresco, Solon, OH), 13 l of mutanolysin (11.7 U l1;
Sigma-Aldrich), and 3 l of lysostaphin (4.5 U l1; Sigma-Aldrich) for an incubation of 30 min at 37°C
and, second, using 10 l proteinase K (20 mg ml1; Research Products International, Mt. Prospect, IL),
50 l 10% SDS, and 2 l RNase (10 mg ml1) for an incubation of 45 min at 56°C. After the enzyme
treatments, cells were disrupted by bead beating in tubes with lysing matrix B (0.1-mm silica spheres; MP
Biomedicals, Solon, OH), at 6 m s1 for 40 s at room temperature in a FastPrep-24 (MP Biomedicals). The
resulting crude lysate was processed using the ZR fecal DNA miniprep kit (Zymo, Irvine, CA) according
to the manufacturer’s recommendations. The samples were eluted with 100 l of ultrapure water into
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separate tubes. DNA concentrations in the samples were measured using the Quant-iT PicoGreen
double-stranded DNA (dsDNA) assay kit (Molecular Probes, Invitrogen, Carlsbad, CA).
16S rRNA gene sequence analysis. Hypervariable regions V3 and V4 of the bacterial 16S rRNA gene
were ampliﬁed with primers 319F and 806R as described previously (38). The libraries were sequenced
on 250PE MiSeq runs. Quality trimming of these sequences was carried out using the procedures
described previously (38) for 250-bp reads according to the following criteria: (i) reads were truncated
upstream of 2 consecutive low-quality bases, (ii) no reads with ambiguous base calls were used, and
(iii) reads with 150 bp after trimming were discarded. Demultiplexing was performed with QIIME
(version 1.8.0) (39). UCHIME v5.1 was conducted for de novo chimera detection and removal. Sequences
were clustered as operational taxonomic units (OTUs) based on a 97% cutoff with USEARCH. Taxonomic
ranks were assigned to each sequence with the Ribosomal Database Project (RDP) Naive Bayesian
Classiﬁer v.2.2, using the Greengenes database of 16S rRNA gene sequences (August 2013) and a
conﬁdence value cutoff of 0.97.
RNA extraction and sequencing. Total RNA was extracted using a protocol described by Eloe-
Fadrosh et al. (16). Brieﬂy, cells from 250 l homogenized stool were lysed using acid phenol, SDS, and
aggressive bead beating using lysing matrix tubes (Qbiogene) and a FastPrep FP120 instrument
(Qbiogene). Total RNA was extracted by three rounds of phenol-chloroform-isoamyl alcohol (IAA)
extraction, ethanol precipitation, and DNase treatment using the Ambion Turbo DNA-free kit (Invitrogen
catalog no. AM1907) followed by puriﬁcation using a Qiagen RNeasy kit (catalog no. 74104) and quality
control using an Agilent 2100 Expert Bioanalyzer. Contamination of genomic DNA was evaluated by 16S
rRNA gene PCR. Subsequently, rRNA was depleted using a combined Gram-positive and Gram-negative
Ribo-Zero rRNA removal kit (Epicentre Technologies) followed by a puriﬁcation step using a Zymo RNA
Clean and Concentrator kit (catalog no. R1015) and quality control using an Agilent RNA 6000 Nano kit
(catalog no. 5067-1511). This protocol generally yields 150 to 300 ng from an initial input of 5 g total
RNA. Following a variation of the manufacturer’s protocol, the TruSeq RNA sample preparation kit
(Illumina) was used to prepare RNA-seq libraries containing 6-bp indexes. Using AMPure XT beads
(Beckman Coulter Genomics), cDNA was puriﬁed and library size selection was performed. Sequencing
was performed using the Illumina HiSeq2000 platform with three samples multiplexed per lane. RNA
extracted from the same samples as for RNA-seq was used to perform qRT-PCR (see Text S1 and
Table S2 in the supplemental material).
RNA-seq taxonomic identification and differential expression analysis. Raw sequence data were
processed with adaptive quality trimming and adapter removal using in-house quality control (QC)
pipelines. rRNA was ﬁltered out by aligning reads using Bowtie 2 (40) to rRNA reference sequence
database SILVA Parc (41). The rRNA-ﬁltered reads were analyzed with BMTagger (42) to identify putative
human sequences that were then removed. The remaining reads were ﬁrst used for taxonomical proﬁling
by MetaPhlAn (15) followed by transcriptome proﬁling by HUMAnN2 (the HMP Uniﬁed Metabolic
Analysis Network), in which nucleotide-level searches were conducted via Bowtie 2 against a functionally
annotated pangenome database, ChocoPhlAn, and unmapped reads were searched on a translational
level via Diamond (43). The resulting UniRef50 gene families were mapped to KEGG Orthogroups (KOs)
and Gene Ontology (GO). Differential gene expression analysis was conducted with edgeR to study both
global and genus-level gene expression patterns (44). The trimmed mean of M values (TMM) was utilized
to estimate appropriate scaling factors for normalization among samples with the inherent assumption
that the majority of counts are not differentially expressed (45).
Clustering of taxonomic composition. We removed any genus estimates less than 1% and 0.3% of
sample sequences obtained from 16S rRNA gene sequencing and RNA sequencing, respectively, and
then renormalized the remaining genus-level abundance estimates to sum to 1.0 for each sample. We
next computed the mean and standard deviation (SD) of observed estimates for each predicted genus
across all samples. Using these data, we mapped all remaining abundance estimates for each genus into
a [0,1] range representing relative deviation from the genus’s mean abundance estimate in SD units. Our
method involves Euclidean-space clustering, where the relevance of absolute values would, without this
ﬁnal normalization, force our method to focus only on the most-abundant genera when identifying
similarity between samples. The clustering tool that we used as a core subroutine was cluster 3.0
(http://bonsai.hgc.jp/~mdehoon/software/cluster/software.htm). This tool performs k-means Euclidean-
space clustering on a given set of vectors for a given value of k. We avoided the issue entirely by varying
k between 3 and 20 inclusive and then ran cluster 1,000 times for each k.
qRT-PCR. The expression level of a subset of transcripts present in baseline samples was determined
using qRT-PCR. DNA and RNA were copuriﬁed from the same stool samples used for RNA-seq using the
MagAttract PowerMicrobiome DNA/RNA kit (Qiagen) using an automated liquid handling system. Total
RNA was prepared from DNA/RNA through two rounds of DNase treatment using Turbo DNAfree enzyme
(Ambion) according to the rigorous DNase treatment protocol. Complete digestion of DNA was con-
ﬁrmed by performing a 35-cycle endpoint PCR for the 16S rRNA gene, targeting the V3-V4 (nucleotide
[nt ]318 to 806) amplicon region. Total RNA was converted to cDNA using SuperScript III reverse
transcriptase according to the manufacturer’s protocol (Invitrogen) and with the use of random hexamer
primers. The cDNA was diluted 1:20 into nuclease-free water (Ambion) before analysis using reverse
transcription-quantitative PCR (qPCR). The qPCR was performed using SYBR green master mix (Life
Technologies) with 10-l reaction mixtures comprised of the following: 5 l of 2 SYBR master mix, 1 l
of each of the 1 M forward and reverse primers (Table S1), 1 l of nuclease-free water (Ambion), and
2 l of cDNA. Triplicate reactions were performed for each cDNA template and primer combination using
a CFX 384 qPCR instrument (Bio-Rad). The qPCR conditions were as follows: 40 cycles of 95°C for 15 s and
60°C for 1 min, followed by a dissociation stage. The cycle threshold (CT) values were calculated using the
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Bio-Rad software. The CT values of the biological replicates were averaged, and the standard deviation
was calculated. The CT values of target genes of each sample were normalized by subtracting from them
the CT value of the constitutively expressed RNA polymerase beta subunit, rpoB, resulting in the ΔCT value
of a particular gene for each sample.
Accession number(s). All subject data have been deposited in NCBI’s database of Genotypes and
Phenotypes (dbGaP) under study accession no. phs001521.v1.p1 and are accessible to authorized users
according to the NIH dbGAP system policies and procedures. Sequence reads from the 16S rRNA gene
proﬁling and metatranscriptomic experiments are available at SRA under accession number
PRJNA407499.
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